SPHRF (SPHRF) Stock Price & Analysis
SPHRF (SPHRF) rose 0.00% to USD 0.47 as of September 10, 2026 at 00:18 UTC, according to Nexqual real-time market data.
SPHRF last closed at USD 0.47; the session ranged USD 0.35–0.35 on volume of 6,475 shares. Market capitalization is $224.22M, with a 52-week range of USD 0.1–0.58 (OQX). Source: Nexqual, September 10, 2026 at 00:18 UTC.
Key Statistics (as of September 10, 2026 at 00:18 UTC)
| Price | USD 0.47 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 0.47 |
| Open | USD 0.35 |
| Day Range | USD 0.35 – 0.35 |
| 52-Week Range | USD 0.1 – 0.58 |
| Volume | 6,475 shares |
| Market Cap | $224.22M |
| Exchange | OQX |
Technical Analysis (SPHRF)
Nexqual's technical model rates SPHRF "SELL" based on 2 bullish and 5 bearish signals across 126 daily candles, as of September 10, 2026 at 00:18 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 0 (oversold) |
| vs SMA50 | Below (USD 0.51) |
| MACD | -0.01 (negative) |
Analyst Ratings (SPHRF)
Wall Street analysts rate SPHRF "None", per Nexqual as of September 10, 2026 at 00:18 UTC.
| Consensus Rating | None |
|---|
Earnings (SPHRF)
Source: Nexqual, September 10, 2026 at 00:18 UTC.
Financials & Fundamentals (SPHRF)
| Total Revenue | $12.67M |
|---|---|
| Revenue Growth (YoY) | -55.80% |
| Gross Margin | +6.11% |
| Operating Margin | -583.74% |
| Profit Margin | -58.93% |
| ROE | -45.55% |
| Debt / Equity | 5.13 |
| Current Ratio | 3.4 |
| Total Cash | $11.02M |
| Total Debt | $707,000 |
| Free Cash Flow | $-708,625 |
Source: Nexqual, September 10, 2026 at 00:18 UTC.
Financial Health Score (SPHRF)
Nexqual rates SPHRF's overall financial health "Weak" across five dimensions, as of September 10, 2026 at 00:18 UTC.
| Growth | Critical — Revenue -56% YoY (latest Q), sharp decline |
|---|---|
| Profitability | Critical — Heavily loss-making — early-stage company |
| Balance Sheet | Strong — $11M cash, no debt |
| Cash Flow | Weak — FCF negative: -$709K, burning cash |
| Efficiency | Critical — ROE -46%, ROA -21.0% |
Ownership (SPHRF)
| Insider Ownership | +29.89% |
|---|---|
| Institutional Ownership | +24.61% |
| Shares Outstanding | 477.05M |
| Float | 350.04M |
Source: Nexqual, September 10, 2026 at 00:18 UTC.
Leadership (SPHRF)
SPHRF is led by Miranda Sowden, Director of People & Culture, per Nexqual as of September 10, 2026 at 00:18 UTC.
| Director of People & Culture | Miranda Sowden |
|---|
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| SPHRY | Starpharma Holdings Ltd. | USD 5.35 | ▲ 2.88% |
| PHGUF | Pharming Group NV | USD 1.1 | ▲ 0% |
| VBIZF | Viva Biotech Holdings | USD 0.19 | ▲ 0% |
| ACHFF | Arch Biopartners Inc. | USD 0.69 | ▼ 6.35% |
| NNBP | NANOBAC PHARMACEUTICALS INC | USD 0 | ▲ 0% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 10, 2026 at 00:18 UTC. This page is informational and not investment advice.